
Browsing restrictions can be lifted for a fee.
Ho Tung Chemical Corp. develops, manufactures, markets, exports, and sells various chemical products in Taiwan, China, Southeast Asia, and internationally. The company offers normal paraffin; linear alkylbenzene sulfonate produced as intermediate in the production of surfactants for use in detergent; anionic surfactants, including linear alkylbenzene sulphonic acid, and alcohol ether sulfates or sodium laureth sulphate; and cationic surfactants, such as palmityl tri-methyl ammonium chloride, stearyl tri-methyl ammonium chloride, and alkyl dimethyl benzyl ammonium chloride. It also provides non-ionic surfactants comprising fatty alcohols, fatty alcohol ethoxylates, and coconut diethanol amide; cocamidopropyl betaine and dodecyl dimethyl betaine; and de-aromatic solvents used in paints and coatings, consumer products, printing inks, and agricultural chemical applications. In addition, the company engages in the trading of oil and other goods; wholesale and trading of chemicals and fuels; leasing of oil reservoir; manufacture and sale of cement and cement raw materials, PMMA light guide plate, and various commodities; development of new energy and surfactant; and general investment activities. The company was incorporated in 1980 and is based in New Taipei City, Taiwan.
1714
和桐
-1.03%
(-0.01)
The most recent financial report for 和桐 (1714) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1714's short-term business performance and financial health. For the latest updates on 1714's earnings releases, visit this page regularly.
According to historical valuation range analysis, 和桐 (1714)'s current price-to-earnings (P/E) ratio is 5.88, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.
According to the latest financial report, 和桐 (1714) reported an Operating Profit of 286.83M with an Operating Margin of 4.8% this period, representing a growth of 66.5% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, 和桐 (1714) announced revenue of 5.97B, with a Year-Over-Year growth rate of 17.15%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
At the end of the period, 和桐 (1714) held Total Cash and Cash Equivalents of 5.74B, accounting for 0.25 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, 和桐 (1714) achieved the “three margins increasing” benchmark, with a gross margin of 9.73%%, operating margin of 4.8%%, and net margin of 5.03%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1714's profit trajectory and future growth potential.
According to the past four quarterly reports, 和桐 (1714)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.17. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
和桐 (1714)'s Free Cash Flow (FCF) for the period is -354.16M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 7,078.5% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.